It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The genetics underlying tuberculosis (TB) pathophysiology are poorly understood. Human genome-wide association studies have failed so far to reveal reproducible susceptibility loci, attributed in part to the influence of the underlying Mycobacterium tuberculosis (Mtb) bacterial genotype on the outcome of the infection. Several studies have found associations of human genetic polymorphisms with Mtb phylo-lineages, but studies analysing genome-genome interactions are needed. By implementing a phylogenetic tree-based Mtb-to-human analysis for 714 TB patients from Thailand, we identify eight putative genetic interaction points (P < 5 × 10−8) including human loci DAP and RIMS3, both linked to the IFNγ cytokine and host immune system, as well as FSTL5, previously associated with susceptibility to TB. Many of the corresponding Mtb markers are lineage specific. The genome-to-genome analysis reveals a complex interactome picture, supports host-pathogen adaptation and co-evolution in TB, and has potential applications to large-scale studies across many TB endemic populations matched for host-pathogen genomic diversity.
Few genetic loci have been associated with tuberculosis infection, possibly because of the influence of genetic variation in the pathogen. Here, the authors integrate human and Mycobacterium tuberculosis genetics to find genome-genome interactions associated with infection.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Gomez-Gonzalez, Paula Josefina 1 ; Andreu, Nuria 1 ; Omae, Yosuke 2 ; Toyo-Oka, Licht 2
; Yanai, Hideki 3 ; Miyahara, Reiko 4 ; Nedsuwan, Supalert 5 ; de Sessions, Paola Florez 6 ; Campino, Susana 1
; Sallah, Neneh 1
; Parkhill, Julian 7
; Smittipat, Nat 8 ; Palittapongarnpim, Prasit 8 ; Mushiroda, Taisei 9 ; Kubo, Michiaki 9
; Tokunaga, Katsushi 2 ; Mahasirimongkol, Surakameth 10 ; Hibberd, Martin L. 1
; Clark, Taane G. 11
1 London School of Hygiene and Tropical Medicine, Faculty of Infectious and Tropical Diseases, London, United Kingdom (GRID:grid.8991.9) (ISNI:0000 0004 0425 469X)
2 The University of Tokyo, Department of Human Genetics, Graduate School of Medicine, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
3 Japan Anti-Tuberculosis Association, Fukujuji Hospital and Research Institute of Tuberculosis, Kiyose, Japan (GRID:grid.419151.9) (ISNI:0000 0001 1545 6914)
4 National Center for Global Health and Medicine, Genome Medical Science Project, Tokyo, Japan (GRID:grid.45203.30) (ISNI:0000 0004 0489 0290)
5 Chiangrai Prachanukroh Hospital, Chiangrai, Thailand (GRID:grid.477048.8)
6 Genome Institute of Singapore, One North, Singapore (GRID:grid.418377.e) (ISNI:0000 0004 0620 715X)
7 University of Cambridge, Department of Veterinary Medicine, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
8 National Science and Technology Development Agency, National Center for Genetic Engineering and Biotechnology, Pathumthani, Thailand (GRID:grid.425537.2) (ISNI:0000 0001 2191 4408)
9 RIKEN Center for Integrative Medical Sciences, Yokohama, Japan (GRID:grid.509459.4) (ISNI:0000 0004 0472 0267)
10 Ministry of Public Health, Medical Genetics Center, Medical Life Sciences Institute, Department of Medical Sciences, Nonthaburi, Thailand (GRID:grid.415836.d) (ISNI:0000 0004 0576 2573)
11 London School of Hygiene and Tropical Medicine, Faculty of Infectious and Tropical Diseases, London, United Kingdom (GRID:grid.8991.9) (ISNI:0000 0004 0425 469X); London School of Hygiene & Tropical Medicine, Faculty of Epidemiology and Population Health, London, United Kingdom (GRID:grid.8991.9) (ISNI:0000 0004 0425 469X)




